Latest Insider Transactions at Aclaris Therapeutics, Inc. (ACRS)
This section provides a real-time view of insider transactions for Aclaris Therapeutics, Inc. (ACRS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aclaris Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aclaris Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 05
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
123,017
+0.91%
|
$123,017
$1.15 P/Share
|
|
Jul 03
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
143,288
+1.06%
|
$143,288
$1.16 P/Share
|
|
Jul 02
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
86,092
+0.65%
|
$86,092
$1.14 P/Share
|
|
Jul 01
2024
|
Neal Walker INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,722
-0.21%
|
$2,722
$1.15 P/Share
|
|
Jul 01
2024
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,467
+0.72%
|
-
|
|
Jul 01
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
107,434
+0.81%
|
$107,434
$1.14 P/Share
|
|
Jun 28
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
1,201,000
+4.49%
|
$1,201,000
$1.13 P/Share
|
|
Jun 27
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
235,000
+1.95%
|
$235,000
$1.15 P/Share
|
|
Jun 18
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
50,000
+0.43%
|
$50,000
$1.13 P/Share
|
|
Jun 17
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
150,000
+1.29%
|
$150,000
$1.13 P/Share
|
|
Jun 14
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
345,000
+2.95%
|
$345,000
$1.17 P/Share
|
|
Jun 13
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
528,621
+2.31%
|
$528,621
$1.15 P/Share
|
|
Jun 12
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
82,579
+0.78%
|
$82,579
$1.14 P/Share
|
|
Jun 11
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+8.78%
|
$1,000,000
$1.08 P/Share
|
|
Jun 01
2024
|
Andrew N Schiff |
BUY
Exercise of conversion of derivative security
|
Direct |
4,660
+33.7%
|
-
|
|
Jun 01
2024
|
Anand Mehra |
BUY
Exercise of conversion of derivative security
|
Direct |
4,660
+9.7%
|
-
|
|
Jun 01
2024
|
Maxine Gowen |
BUY
Exercise of conversion of derivative security
|
Direct |
4,660
+21.55%
|
-
|
|
Jun 01
2024
|
William D. Humphries |
BUY
Exercise of conversion of derivative security
|
Direct |
4,660
+13.96%
|
-
|
|
Jun 01
2024
|
Vincent Milano |
BUY
Exercise of conversion of derivative security
|
Direct |
4,660
+27.12%
|
-
|
|
Jun 01
2024
|
Christopher P. Molineaux |
BUY
Exercise of conversion of derivative security
|
Direct |
4,660
+8.06%
|
-
|
|
Jun 01
2024
|
Andrew Kenneth William Powell |
BUY
Exercise of conversion of derivative security
|
Direct |
4,660
+12.2%
|
-
|
|
Jun 01
2024
|
Bryan M. Reasons |
BUY
Exercise of conversion of derivative security
|
Direct |
4,660
+13.96%
|
-
|
|
Jun 01
2024
|
Neal Walker INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,722
-0.21%
|
$2,722
$1.03 P/Share
|
|
Jun 01
2024
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,466
+0.72%
|
-
|
|
May 01
2024
|
Neal Walker INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,784
-0.22%
|
$2,784
$1.26 P/Share
|
|
May 01
2024
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,467
+0.73%
|
-
|
|
Apr 01
2024
|
Neal Walker INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,224
-0.25%
|
$3,224
$1.26 P/Share
|
|
Apr 01
2024
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,467
+0.73%
|
-
|
|
Mar 04
2024
|
Andrew Kenneth William Powell |
BUY
Open market or private purchase
|
Direct |
6,000
+17.21%
|
$6,000
$1.25 P/Share
|
|
Mar 02
2024
|
Joseph Monahan Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,531
-1.86%
|
$3,531
$1.24 P/Share
|
|
Mar 02
2024
|
Joseph Monahan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+6.16%
|
-
|
|
Mar 02
2024
|
Kevin Balthaser Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-1.75%
|
$427
$1.24 P/Share
|
|
Mar 02
2024
|
Kevin Balthaser Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.79%
|
-
|
|
Mar 01
2024
|
Joseph Monahan Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,752
-4.82%
|
$17,752
$1.24 P/Share
|
|
Mar 01
2024
|
Joseph Monahan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,925
+13.5%
|
-
|
|
Mar 01
2024
|
Neal Walker INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,223
-0.25%
|
$3,223
$1.24 P/Share
|
|
Mar 01
2024
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,466
+0.73%
|
-
|
|
Mar 01
2024
|
Kevin Balthaser Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
990
-2.16%
|
$990
$1.24 P/Share
|
|
Mar 01
2024
|
Kevin Balthaser Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,475
+7.0%
|
-
|
|
Mar 01
2024
|
Andrew Kenneth William Powell |
BUY
Open market or private purchase
|
Direct |
8,500
+27.1%
|
$8,500
$1.23 P/Share
|
|
Feb 01
2024
|
James Loerop Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,421
-9.36%
|
$6,421
$1.2 P/Share
|
|
Feb 01
2024
|
James Loerop Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+21.24%
|
-
|
|
Feb 01
2024
|
Joseph Monahan Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,583
-1.88%
|
$2,583
$1.2 P/Share
|
|
Feb 01
2024
|
Joseph Monahan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+5.18%
|
-
|
|
Jan 01
2024
|
Douglas J. Manion Pres and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,125
-17.91%
|
$9,125
$1.05 P/Share
|
|
Jan 01
2024
|
Douglas J. Manion Pres and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+34.64%
|
-
|
|
Jan 01
2024
|
Kevin Balthaser Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,536
-11.04%
|
$2,536
$1.05 P/Share
|
|
Jan 01
2024
|
Kevin Balthaser Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+24.62%
|
-
|
|
Oct 23
2023
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,000
-4.42%
|
$30,000
$5.08 P/Share
|
|
Sep 06
2023
|
Kevin Balthaser Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
9,490
+38.03%
|
$66,430
$7.9 P/Share
|